Your Buyers Know Your Factory Price. Now What?

Do your buyers know what you pay the factory?

Many of them do, or think they do, and some of them can also see a second, cheaper price list for products like yours in private group chats. You cannot hide either number. What you can control is whether your own price can be explained line by line, and whether you take part in a private price channel at all.

This guide is for founders and operators of research use only (RUO) peptide stores. It is direct on purpose. It covers what buyers say in public about factory prices and private price lists, what the gap between a factory unit price and your shelf price actually pays for, why private channel prices can sit near half of a public price, what running a private price list can expose you to, what federal pricing guides and your payment processor already say about discounts and payment channels, and the three positions an operator can take. Every quotation is copied from its source and cited. Every dollar figure below is a worked example, labeled as one (except a figure one commenter wrote, quoted as theirs), because a real factory quote depends on the item, the lot and the date.

Talk through your pricing and price defense: book a call

Key Facts

• A public commenter wrote that a single search shows "peptide sellers though with prices x10 higher than getting it directly from manufacturers in China." [1]
• Another wrote that in gray markets there is "usually a race to the bottom on price," and that "lab reports are one of the primary ways that customers rank and differentiate between brands." [2]
• A third described a seller's private chat group and waiting for a presale "where it'll be a little above half the price on the web page." [3]
• FDA's intended use regulation says intent may be shown "by the circumstances surrounding the distribution of the article" (21 CFR 201.128). [7]
• The same regulation says intent may be shown "by circumstances in which the article is, with the knowledge of such persons or their representatives, offered or used for a purpose for which it is neither labeled nor advertised." [7]
• In two August 2026 warning letters to peptide sellers, FDA wrote that evidence from the sellers' websites established the products were intended to be drugs, despite research use labeling. [8][9]
• FTC's Guides Against Deceptive Pricing say a former price supports a price comparison when it is "the actual, bona fide price at which the article was offered to the public on a regular basis for a reasonably substantial period of time." [11]
• Stripe's prohibited businesses list includes "Incorrectly labeled research chemicals" (under illegal weapons, explosives, and dangerous materials) and, among prohibited uses of its products, "Evasion of card network chargeback monitoring programs." [14]
• In a worked example built on this site's own hypothetical wholesale figures, a $12 factory unit price becomes a $41.50 break even cost for a one vial order once landed cost, order costs, overhead and acquisition are counted. [5]
• In the same worked example, an open five vial tier at $36 a vial keeps $50.50 on the order, against $16.50 for a five vial presale order at $27 a vial.

TL;DR

• Assume the buyer has seen a factory listing. Price as if every buyer can do the division.
• The factory unit price is not your cost. Landed cost, per order costs, overhead and the cost of finding the buyer all sit between the two numbers.
• Our read: buyers price invisible value at zero. Whatever you pay for that the buyer cannot see (lot testing, documents, a support inbox, a refund policy) does not defend your price until you show it.
• In our worked example, a private channel price near half the public one works only when the order changes: prepaid, bundled, paid off card and found without ads. They are not proof that your public price is padding.
• Our read, which is judgment: running your own private price list adds a second channel FDA can read as part of the "circumstances surrounding the distribution," and in a group where buyers discuss uses outside the research label, it also adds knowledge. [7]
• If you answer a cheaper channel with a sale, the price you compare against has to be a real one. FTC's guides call a bargain false when "an artificial, inflated price was established for the purpose of enabling the subsequent offer of a large reduction." [11]
• Our recommendation: one public price, open quantity tiers for every buyer, and visible evidence for every cost the buyer is paying for. No private price list.

What do buyers actually say about factory prices?

They say it plainly, and they say it in public. We read Hacker News comments from 2025 and 2026 that discuss buying research peptides, as part of the topic research behind this article. Four of them, from three commenters, bear on what a store price is judged against: a factory price, a raw input price, a private presale price, and lab reports. [1][2][3][4]

The bluntest: a single search "will show you peptide sellers though with prices x10 higher than getting it directly from manufacturers in China." [1] That buyer is not describing a hidden fact. They are describing a search result.

A second commenter, writing about gray markets in general, describes them this way: "there's usually a race to the bottom on price, and that everything is easily affordable out of pocket." [2] The same comment says what buyers use to separate brands: "lab reports are one of the primary ways that customers rank and differentiate between brands." [2]

The commenter behind [3], in a separate comment about a different part of the supply chain, put the gap as "$20 worth of API from China" sold "for at least 10x that." [4] That is the commenter's own figure, not a measured price. That comment was about compounding pharmacies, not RUO stores. Our read: it still shows a mental model, in which buyers start from the raw input price and treat everything above it as margin.

Read these for what they are. They are a handful of public comments, not a survey, and the "10x" is the commenters' own figure, not a measured market ratio. But the operator lesson does not depend on the exact multiple. The buyer arrives with a factory number in their head. Your price is judged against that number, not against your cost.

Why is the factory price not your cost?

Because the factory quotes a unit, and you sell an order. Between the two sit at least four layers of cost a factory quote does not cover on its own. This site's guide to how to price peptides separates them this way: the quoted product amount, the cost you actually carry per accepted unit, the expenses of each sale, and the fixed obligations of a period. [6]

Here is that stack as one worked example. The first two rows reuse the hypothetical figures from this site's wholesale price list guide, where a hypothetical 100 vial order at $12.00 per vial becomes $14.00 per accepted vial once freight, packaging and separately budgeted testing are assigned. [5] The other rows are new hypothetical figures, chosen only to make the arithmetic visible. None of them is a real quote, a typical cost, or a target.

| Layer (all figures hypothetical) | Per vial, one vial order | What it covers |

|:--|--:|:--|

| Factory unit price at 100 vials | $12.00 | The number the buyer found |

| Landed cost per accepted vial | $14.00 | Product, freight, packaging, lot testing, spread over vials you accept [5] |

| Per order costs | $10.50 | Card processing $2.00, pick, pack and label $4.00, shipping subsidy $3.00, support and refund reserve $1.50 |

| Period overhead | $8.00 | $4,000 a month (storage, software, compliance review, insurance, bookkeeping) over 500 vials sold |

| Cost to find the buyer | $9.00 | Paid or content acquisition attributed to the order |

| Break even for a one vial order | $41.50 | Landed cost plus the three layers below it |

Price that vial at a hypothetical $49.00 and the store keeps $7.50. The buyer sees a 4.1x multiple over the $12.00 factory price and may call it gouging. The operator sees a 15 percent cushion on a one vial order, before a single refund, chargeback or bad lot.

The whole table reduces to one line you can put in a spreadsheet:

Break even per unit = landed cost per accepted unit + overhead per unit + (per order costs + acquisition cost) ÷ units in the order.

With the hypothetical figures that is $14.00 + $8.00 + $19.50 ÷ units. Only the last term moves with order size, and it is the term a factory quote never shows.

Three things about this table matter more than its numbers.

First, the per order layer does not care how many vials are in the box. Put three vials in the same hypothetical order and the per vial cost drops from $41.50 to $28.50, because the $10.50 of order costs and the $9.00 of acquisition are spread three ways. The same hypothetical $49.00 price then leaves $61.50 on the order instead of $7.50. In this example, order size moves the result more than markup does.

Second, the overhead row is where small stores lose the argument. In the arithmetic of this row, the same fixed costs spread over more units cost less per unit, so a seller with higher volume carries less of it on each vial. A store selling 500 vials a month carries its compliance review, its software and its insurance on every one of them. That is a real cost, and it is also the row a buyer has the least reason to believe.

Third, the buyer's "10x" is not this stack. A 10x price on the hypothetical $12.00 factory unit is $120.00. If your price looks like that, the buyer is right to ask what is in it, and you should be able to answer from your own worksheet. If you cannot, the gap is margin, and you should know that before the buyer tells you.

Markup is the wrong number to defend

When a buyer says 10x, they are quoting a markup: price over factory price. Markup and margin answer different questions. This site's pricing guide gives the formulas: markup percentage divides the dollar difference by the cost basis, gross margin percentage divides it by the selling price, and "State the cost basis every time you use either figure." [6] A store that defends its price with markup is arguing on the buyer's denominator. Argue on yours: the cost per accepted unit and the contribution left after each order.

What is the buyer actually paying you for?

Everything in the gap that the buyer can see and check. Everything else, the buyer treats as zero.

Our working list for an RUO store, each item with how a buyer can verify it:

1. An accepted lot with documents. A certificate of analysis for the specific lot, not a generic one, and a third party test you can name. One commenter wrote that lab reports are how buyers rank brands. [2] See batch specific COA vs generic lot COA and what third party tested actually means.

2. A lot identity that holds. The lot number on the vial matches the lot number on the document, and the document is still current. See what to do when a COA is revised or withdrawn.

3. Domestic stock and a shipping time you state. Our read: a buyer who orders from a factory direct waits for an international shipment and carries the import risk, and a factory unit price includes none of that.

4. A card checkout and a refund policy in writing. For consumer credit cards, federal law counts as a billing error a charge for goods "not delivered to the obligor or his designee in accordance with the agreement made at the time of a transaction." [13] Our read: a buyer who prepays off card in a private channel may have no such path, and a buyer who knows that values your checkout.

5. A support inbox that answers. Somebody responds when a parcel is lost or a lot is in question.

6. A business that will exist next month. The buyer's next order depends on it.

The test for each item is simple: can a buyer who has never ordered from you see it before checkout? If the testing lives in a folder on your laptop, it does not defend your price. If the shipping time is a promise in a chat, it does not defend your price. Put the evidence where the price is.

There is a limit to this. Evidence defends a price only up to the value the buyer puts on it. If a buyer cares only about the factory number, no document will move them, and that buyer is not your customer. That is a decision, not a failure.

What is the Telegram price?

It is a second price list for the same kind of product, sent inside a private group chat instead of shown on a website. The comment we read names Telegram. Our read is that the same pattern can run in any private group channel. The commenter we quoted earlier describes the mechanics in one line: you "can pay full retail" on the website, or join the seller's group "and wait for a pre-sale, where it'll be a little above half the price on the web page." [3]

The description has three parts. The price is lower than the public one. The group is reached from the seller's own site, where it is "listed at the bottom of their page." And the lower price comes through a presale the buyer has to "wait for." [3] The same commenter adds that "once you are on the Telegram group, ask around and people will invite you to" other groups, for other sellers. [3] Our read: a private group is also a place where your buyers meet other sellers.

How can a private price sit near half the public price?

Our read: mostly by changing the shape of the order, not by finding a cheaper factory. Run the same hypothetical stack with assumptions about how a presale order is shaped. The comment does not describe the payment or the order size, so these are assumptions, not observations. A public price of $49.00 at "a little above half" puts the private price near $27.00. [3]

• Sold one vial at a time through a normal store, the hypothetical break even was $41.50. A $27.00 price loses money on every order.
• Assume the buyer prepays off card and the group, not ads, finds the buyers. Remove card processing and acquisition. The one vial cost falls to $30.50. Still a loss at $27.00.
• Now also assume each buyer prepays for five vials, packed and shipped once. The per vial cost falls to $23.70, because the remaining $8.50 of order costs is spread five ways. At $27.00 the seller keeps about $3.30 a vial, and, under the same assumption, the presale cash pays the factory before the stock lands.

So the private price is not proof that the public price is padding. Under these assumptions it is a different business: bulk orders, prepayment, no card fees and no ads. The one part the comment does describe is the wait. [3] The public price funds the things the private channel does not pay for, starting with being found.

What does an open tier earn against a presale?

Now put a public quantity tier next to the presale, with the same hypothetical stack. Two simplifications: card processing stays at $2.00 per order, and the tier prices are illustrations, not recommendations.

| Order (all figures hypothetical) | Price per vial | Cost per vial | Kept per order |

|:--|--:|--:|--:|

| One vial at the public price | $49.00 | $41.50 | $7.50 |

| Three vials, public tier | $41.00 | $28.50 | $37.50 |

| Five vials, public tier | $36.00 | $25.90 | $50.50 |

| Five vials, presale (assumed prepaid, off card, no ads) | $27.00 | $23.70 | $16.50 |

Under these assumptions the five vial tier is about 27 percent below the single vial price, and it keeps about three times what the presale order keeps. Our read: the presale is not the cheaper way to sell. It is the thinner one, held up by cash in advance and a buyer who waits. The tier buyer still pays $9.00 a vial more than the presale buyer. That gap is what your card checkout, stock on the shelf and written refund policy have to be worth to them, which is why the evidence in the previous section has to be visible.

There is a second, uncomfortable point. The private channel can depend on the public site; in the comment we read, the group is "listed at the bottom of their page." [3] Our read: in that setup the site is where buyers find the brand and see the full price that makes the presale look like a deal. Our read, again judgment: the public price then works as the anchor for the private one, and the public buyers pay for the discovery that the private buyers use.

What does a competitor's Telegram price do to your store?

It moves the number your buyer compares you with, again. First the factory price, now a private price that is lower than yours and comes with a community. You will not win a price comparison against a prepaid group buy on a one vial order, and the worked example above shows why. Do not try to. Compete on the parts of the gap that a private channel does not offer: a card checkout, a written refund policy, stock on the shelf, a support inbox, and documents a buyer can read before paying.

Should you run your own private price list?

Our answer is no. Here is the case, risk by risk.

Risk 1: a second channel FDA can read

FDA decides what a product is by its intended use, and its regulation does not limit the evidence to your product page. Intent "may be shown by such persons' expressions, the design or composition of the article, or by the circumstances surrounding the distribution of the article." [7] A private group chat where you post prices and take orders is part of how you distribute. Our read, which is judgment and not a legal ruling: it is part of those circumstances.

The regulation goes one step further. Intent may be shown "by circumstances in which the article is, with the knowledge of such persons or their representatives, offered or used for a purpose for which it is neither labeled nor advertised." [7] (The sentence closes with a proviso that applies to approved drugs.) Our read: a group chat is not a one way price board. Members post to it, and whoever runs the group can see what they post. Our read, again judgment: an operator who hosts a channel where buyers discuss uses outside the research label, and keeps selling into it, is building the "knowledge" that sentence describes.

The research use label does not cancel this out. In both August 2026 warning letters to peptide sellers that we read, FDA wrote that "Despite statements on your product labeling" limiting the products to research use, "evidence obtained from your website establishes that your products are intended to be drugs." [8][9] Those letters were about website evidence. Our read, which is judgment: nothing in them suggests a private channel would be read differently, and a private channel is harder for you to clean up.

FDA has also followed the path from social accounts to the store before. In a 2022 letter to a CBD seller, FDA listed the company's social media accounts and wrote that they "direct consumers to your website" before quoting evidence from the site. [10] Our read, which is judgment: a private group that sends buyers to your checkout is the same kind of path.

For what FDA has cited in peptide sellers' copy, see what FDA warning letters say about peptide marketing.

Risk 2: two prices for the same lot

Your public buyers pay more for the same vial from the same lot. Our read: they will find out. The comment we read describes members inviting newcomers into other sellers' groups. [3] A buyer who sees both prices can compare them. When they find out, the problem is not the price difference. It is that you kept it from them. Our read: that costs more trust than a higher public price ever does.

Risk 3: presale money and delivery risk

Our read: a prepaid presale takes the buyer's money before the stock is in your hands. If the factory slips, the lot fails your test, or the shipment is held, you owe the buyer either product or a refund from cash you already spent on the order. See peptide preorders and shipping delays for how that exposure builds.

Risk 4: payment paths your processor has already named

Processors write some of this down. Stripe's prohibited businesses list includes "Incorrectly labeled research chemicals" (under illegal weapons, explosives, and dangerous materials), and, among prohibited uses of its products, "Evasion of card network chargeback monitoring programs." [14] Braintree's acceptable use policy lists "evading card association chargeback monitoring programs." [15]

Our read, which is judgment: a private presale is often paid outside card checkout, and an operator who sends the orders most likely to be disputed into an off card channel, while keeping the clean orders on card, is building the pattern those lines describe. Read your own processor's restricted and prohibited lists, not a summary, before you take money in a second channel, and never assume a channel is acceptable because it is off card. See peptide payment processors compared and high risk payment processing.

If you discount to answer a private price, is your comparison honest?

Many stores answer a cheaper channel with a sale. FTC's Guides Against Deceptive Pricing describe when a was price is a fair basis for a comparison. A former price is a legitimate basis for a comparison when it is "the actual, bona fide price at which the article was offered to the public on a regular basis for a reasonably substantial period of time." [11] The guides call the bargain false where "an artificial, inflated price was established for the purpose of enabling the subsequent offer of a large reduction." [11]

Zero sales at the old price do not by themselves make it fictitious. But it must be a price "at which the product was openly and actively offered for sale, for a reasonably substantial period of time," and the seller "should scrupulously avoid any implication that a former price is a selling, not an asking price" unless "substantial sales at that price were actually made." [11]

What that means for an operator, as our read:

1. Do not raise a price to cut it. A price posted for a few days before a sale is the pattern in the guides' own example of a fictitious former price. [11]

2. Watch the words. Regularly $49 claims less than Was selling at $49. If almost no one bought at $49, say less.

3. Keep a dated price log. For each product, record when each price was posted and how many orders it took. That log is your evidence if anyone asks whether your comparison was real.

Our read, again judgment: a public price kept mainly so a private presale can be called half off is close to the pattern the guides describe, even though their examples concern a former price rather than a parallel channel. The guides are FTC guidance under the FTC Act; state law may add its own rules on former prices, which this article does not cover.

What are your three options?

You can take one of three positions on price. Pick one on purpose.

Option A: compete on price. Become the low cost store. This works only if your stack is actually lean: high volume, low overhead, larger average orders. You give up most of the gap that pays for documents and support, and you compete with factories and private channels on their ground. Our read: few new stores can win here.

Option B: defend a premium with evidence. Keep a higher public price and make every cost the buyer pays for visible: lot documents, the testing lab, the shipping time, the refund policy, the support contact. You do not publish your cost numbers. You publish the categories, so the buyer can see what the gap buys.

Option C: open quantity tiers for everyone. The honest version of a group buy is a public quantity break. If three vials in one order cost you far less per vial than one, as the worked example shows, offer that saving on the product page, to every buyer, at the same terms. You capture the order size advantage of a private channel without a private channel. The wholesale guide shows how to test a tier ladder against your cash commitment before you publish it. [5]

The same logic applies to the card fee a presale avoids. Federal law bars a card network from inhibiting "a discount or in-kind incentive for payment by the use of cash, checks, debit cards, or credit cards," as long as a card discount "does not differentiate on the basis of the issuer or the payment card network" and, to the extent federal and state law require, is "offered to all prospective buyers and disclosed clearly and conspicuously." [12] Our read: a disclosed discount for a cheaper payment method, offered on the product page to everyone and allowed by your processor agreement, is the public version of the off card saving a presale keeps for itself. Check that agreement and your state's rules first.

Our recommendation: B and C together. One public price, open tiers, visible evidence. No private list.

Build your price defense sheet

Before a buyer asks, answer these in writing. Keep the sheet next to your pricing worksheet.

1. What is the factory unit price a buyer can find for this item? Write it down. Assume they have it.

2. What is your cost per accepted unit? Use the landed cost method in the wholesale guide, with freight, packaging and testing assigned. [5]

3. What are your per order costs, and what is the break even for a one unit order? If your price is below it, you lose money on small orders. Know that.

4. What does a three unit order leave you? If the answer is far higher, you have a tier to publish.

5. Which items on the what the buyer pays for list can a new buyer see before checkout? Every item they cannot see is priced at zero.

6. What is your ratio of price to factory price, and can you explain every layer of it from this sheet? If not, the unexplained part is margin. Decide whether you can defend it.

7. Does anyone in your business, or acting for it, post prices or take orders in a private channel? If yes, decide now whether to close it, and read Risk 1 again.

8. If you advertise a discount against your own price, can you show when that price was posted and that it was openly offered? If not, start a dated price log before the next sale. [11]

9. Does your processor's restricted and prohibited list allow every channel you take money in? Read the list itself, not a summary of it. [14][15]

What you should have when you finish

• A written cost stack for each product, from factory price to one unit break even, with every figure sourced to a quote, invoice or stated estimate.
• A public quantity tier, tested against the cash it commits, or a written reason why you do not offer one.
• A product page that shows the lot document, the testing lab, the shipping time, the refund policy and the support contact.
• A dated price log for each product, so every was price you publish can be shown to be real.
• A written decision on private price channels, with the name of the person who owns it.

Frequently Asked Questions

Do customers really compare my price with factory prices?

Some say so in public. One commenter wrote that a search shows sellers with "prices x10 higher than getting it directly from manufacturers in China." Assume your buyers can find a factory listing and price as if they have.

Is a 4x or 10x markup over the factory price unfair?

The multiple alone does not say. In a hypothetical stack built on this site's wholesale example, a $12.00 factory unit price carries a $41.50 break even on a one vial order. What matters is whether your own stack explains your price.

Why are private group chat prices so much lower?

The buyer comment we read puts presale prices "a little above half the price on the web page." In our worked example, which rests on stated assumptions, that price works only for prepaid, bundled orders paid off card with no acquisition cost. Our read: it reflects a different order shape, not a cheaper product.

Is it legal to run a private price list for a research peptide store?

That is a question for your own counsel. What FDA's regulation says is that intended use may be shown by "the circumstances surrounding the distribution of the article," and by what a seller knows a product is used for. Our read, which is judgment: a private channel adds to both.

Should I match a competitor's private presale price?

Our recommendation is no. Compete on what a private channel does not offer: a card checkout, a written refund policy, stock on hand, support, and lot documents a buyer can read before paying.

What is a fair way to give buyers a lower price?

A public quantity tier offered to every buyer on the same terms. It passes on the real saving of larger orders without a hidden second price. In our worked example, a five vial tier at $36 a vial keeps more on the order than a five vial presale at $27.

Can I advertise a sale as half off my site price?

Only if the site price is real. FTC's guides accept a former price that was "openly and actively offered for sale, for a reasonably substantial period of time," and call a bargain false when the higher price was set to make a large reduction possible. Keep a dated record of your prices and ask counsel about the states you sell into.

Can I give a lower price for paying by bank transfer instead of card?

The federal rule on payment method discounts names "cash, checks, debit cards, or credit cards" and does not name bank transfer. It limits what card networks may do, and where federal or state law requires it, the discount must be "offered to all prospective buyers and disclosed clearly and conspicuously." Our read: a bank transfer discount is a question for your processor agreement and your state's rules, not for this statute, so check both before you publish one.

Sources

1. Hacker News, comment 44809991. Collected 24 October 2026.

2. Hacker News, comment 46168271. Collected 24 October 2026.

3. Hacker News, comment 46168760. Collected 24 October 2026. Quoted for the buyer's description of channel mechanics only; product and seller details in the comment are not repeated.

4. Hacker News, comment 46930537. Collected 24 October 2026.

5. Peptide Ecommerce, Peptide Wholesale Price List: MOQs, Tiers and Quotes, sections "Test the cash commitment with a hypothetical ladder" and "Work a matching-quantity hypothetical." Site's own hypothetical figures. Read 24 October 2026.

6. Peptide Ecommerce, How to Price Peptides: A Founder Cost Model, sections "Calculate markup and gross margin with different denominators" and "Build a blank cost stack with field level provenance." Read 24 October 2026.

7. U.S. Electronic Code of Federal Regulations, 21 CFR 201.128, Meaning of "intended uses". Read 8 October 2026.

8. U.S. Food and Drug Administration, Warning Letter 733652, 24 August 2026, footnote 1. Read 8 October 2026.

9. U.S. Food and Drug Administration, Warning Letter 735063, 24 August 2026, footnote 1. Read 8 October 2026.

10. U.S. Food and Drug Administration, Warning Letter 629243, 16 November 2022. Read 23 October 2026.

11. Code of Federal Regulations, 16 CFR 233.1, Former price comparisons, part of FTC's Guides Against Deceptive Pricing, 2025 edition. Read 24 October 2026.

12. United States Code, 15 U.S.C. 1693o-2(b)(2), Limitation on restrictions on offering discounts for use of a form of payment, 2023 edition. Read 24 October 2026.

13. United States Code, 15 U.S.C. 1666(b)(3), Correction of billing errors, 2023 edition. Read 24 October 2026.

14. Stripe, Prohibited and Restricted Businesses. Read 8 October 2026.

15. Braintree, Acceptable use policy, section 2, Certain Business Categories, last updated 8 November 2017. Read 8 October 2026.

Educational and legal disclaimer

This article is general education about business operations for research peptide stores. It is not legal, regulatory, financial or medical advice, and it describes no use of any product in people or animals. All dollar figures are hypothetical worked examples, not quotes, typical costs or targets. Public comments are quoted as examples of what some buyers say, not as a measure of the market. Warning letters describe the facts of each recipient's case. Obtain qualified advice for your specific business before changing how you price, sell or take payment.